Definition of Moxetumomab. Meaning of Moxetumomab. Synonyms of Moxetumomab

Here you will find one or more explanations in English for the word Moxetumomab. Also in the bottom left of the page several parts of wikipedia pages related to the word Moxetumomab and, of course, Moxetumomab synonyms and on the right images related to the word Moxetumomab.

Definition of Moxetumomab

No result for Moxetumomab. Showing similar results...

Meaning of Moxetumomab from wikipedia

- Moxetumomab pasudotox, sold under the brand name Lumoxiti, is an anti-CD22 immunotoxin medication for the treatment of adults with relapsed or refractory...
- rituximab, the combination can be retried. Or the anti-CD22 immunotoxin moxetumomab pasudotox can be tried. Or a BRAF inhibitor can be restarted plus MEK...
- was developed at the NIH. BL22 was su****ded by moxetumomab pasudotox (HA22, CAT-8015). Moxetumomab pasudotox is approved in the EU and USA for treatment...
- (INN) moxastine (INN) moxaverine (INN) moxazocine (INN) moxestrol (INN) moxetumomab pasudotox (INN) moxicoumone (INN) moxidectin (INN) moxifloxacin (INN)...
- immunomodulatory agent, proteasome inhibitor and anti-CD38 antibody Moxetumomab pasudotox Lumoxiti AstraZeneca relapsed or refractory hairy cell leukemia...
- Ofatumumab L01FA03 Obinutuzumab L01FB01 Inotuzumab ozogamicin L01FB02 Moxetumomab pasudotox L01FC01 Daratumumab L01FC02 Isatuximab L01FD01 Trastuzumab...
- Isatuximab Loncastuximab tesirine Mirvetuximab soravtansine Mogamulizumab Moxetumomab pasudotox Naxitamab Necitumumab Nivolumab (+hyaluronidase, +relatlimab)...
- respiratory syncytial virus respiratory syncytial virus (prevention) Moxetumomab pasudotox Lumoxiti mab mouse CD22 Y hairy cell leukemia Muromonab-CD3...
- trials included: durvalumab (anti-PD-L1) tremelimumab (anti-CTLA-4) moxetumomab pasudotox (anti-CD22) benralizumab (anti-IL-5R) tralokinumab (anti-IL-13)...
- tested in humans with various forms of cancer. One of these, HA22 or Moxetumomab pasudotox (Moxe), targets CD22 on B cell malignancies; it has produced...